These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 3388296

  • 1. Pharmacokinetics of dermatan sulfate in the rabbit after intravenous injection.
    Dol F, Houin G, Dupouy D, Cadroy Y, Caranobe C, Gabaig AM, Mardiguian J, Sié P, Boneu B.
    Thromb Haemost; 1988 Apr 08; 59(2):255-8. PubMed ID: 3388296
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of heparin and related polysaccharides.
    Boneu B, Dol F, Caranobe C, Sie P, Houin G.
    Ann N Y Acad Sci; 1989 Apr 08; 556():282-91. PubMed ID: 2544127
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological properties of dermatan sulfate, of a low molecular weight dermatan sulfate and of two oversulfated derivatives.
    Dol F, Petitou M, Choay J, Sie P, Houin G, Boneu B.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989 Apr 08; 116(6):851-7. PubMed ID: 2483702
    [Abstract] [Full Text] [Related]

  • 4. Standard heparin enhances the antithrombotic activity of dermatan sulfate in the rabbit but CY 216 does not.
    Cadroy Y, Dol F, Caranobe C, Petitou M, Lormeau JC, Sié P, Choay J, Boneu B.
    Thromb Haemost; 1988 Apr 08; 59(2):295-8. PubMed ID: 2838927
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and pharmacodynamics of dermatan sulfate after intravenous and intramuscular administration to healthy volunteers.
    Blardi P, Messa GL, Urso R, Di Perri T.
    Int J Clin Pharmacol Res; 1993 Apr 08; 13(4):231-8. PubMed ID: 8150550
    [Abstract] [Full Text] [Related]

  • 6. A simple method to measure dermatan sulfate at sub-microgram concentrations in plasma.
    Dupouy D, Sié P, Dol F, Boneu B.
    Thromb Haemost; 1988 Oct 31; 60(2):236-9. PubMed ID: 3217919
    [Abstract] [Full Text] [Related]

  • 7. Pharmacologic properties of a low molecular weight dermatan sulfate: comparison with unfractionated dermatan sulfate.
    Dol F, Petitou M, Lormeau JC, Choay J, Caranobe C, Sie P, Saivin S, Houin G, Boneu B.
    J Lab Clin Med; 1990 Jan 31; 115(1):43-51. PubMed ID: 2299256
    [Abstract] [Full Text] [Related]

  • 8. Human pharmacokinetics and pharmacodynamics of MF 701 dermatan sulfate administered by continuous intravenous infusion.
    Agnelli G, Cosmi B, Renga C, Federici F, Nenci GG, Houin G, Gianese F.
    Thromb Haemost; 1990 Oct 22; 64(2):256-9. PubMed ID: 2270533
    [Abstract] [Full Text] [Related]

  • 9. Pharmacodynamics and pharmacokinetics of dermatan sulfate in humans.
    Dol F, Houin G, Rostin M, Montastruc JL, Dupouy D, Gianese F, Sie P, Boneu B.
    Blood; 1989 Oct 22; 74(5):1577-82. PubMed ID: 2790187
    [Abstract] [Full Text] [Related]

  • 10. [Dermatan sulfate and the prevention of experimental venous thrombosis].
    Desnoyers P, Bara L, Samama M.
    Pathol Biol (Paris); 1989 Jun 22; 37(6):759-67. PubMed ID: 2674877
    [Abstract] [Full Text] [Related]

  • 11. Determination of plasma dermatan sulfate at relevant pharmacological concentrations.
    Sié P, Dupouy D, Dol F, Boneu B.
    Semin Thromb Hemost; 1991 Jun 22; 17 Suppl 2():181-5. PubMed ID: 1948089
    [Abstract] [Full Text] [Related]

  • 12. The pharmacokinetics of LMW dermatan sulphate: long-term persistence of intact material.
    Dawes J.
    Thromb Haemost; 1993 Apr 01; 69(4):339-43. PubMed ID: 8497846
    [Abstract] [Full Text] [Related]

  • 13. Effects of heparin, dermatan sulfate and of their association on the inhibition of venous thrombosis growth in the rabbit.
    Carrie D, Caranobe C, Gabaig AM, Larroche M, Boneu B.
    Thromb Haemost; 1992 Dec 07; 68(6):637-41. PubMed ID: 1287877
    [Abstract] [Full Text] [Related]

  • 14. Experimental studies on the relative efficacy of dermatan sulphate and heparin as antithrombotic agents.
    Merton RE, Thomas DP.
    Thromb Haemost; 1987 Oct 28; 58(3):839-42. PubMed ID: 3433248
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous determination of dermatan sulfate and oversulfated dermatan sulfate in plasma by high-performance liquid chromatography with postcolumn fluorescence derivatization.
    Huang Y, Washio Y, Hara M, Toyoda H, Koshiishi I, Toida T, Imanari T.
    Anal Biochem; 1996 Sep 05; 240(2):227-34. PubMed ID: 8811915
    [Abstract] [Full Text] [Related]

  • 16. The relationship between the structure of dermatan sulfate derivatives and their antithrombotic activities.
    Du HY, Ji SL, Song HF, Ye QN, Cao JC.
    Thromb Res; 2007 Sep 05; 119(3):377-84. PubMed ID: 17097136
    [Abstract] [Full Text] [Related]

  • 17. The absorption, clearance and metabolic fate of dermatan sulphate administered to man--studies using a radioiodinated derivative.
    Dawes J, Hodson BA, Pepper DS.
    Thromb Haemost; 1989 Nov 24; 62(3):945-9. PubMed ID: 2595665
    [Abstract] [Full Text] [Related]

  • 18. Effects of increased sulfation of dermatan sulfate on its in vitro and in vivo pharmacological properties.
    Dol F, Caranobe C, Dupouy D, Petitou M, Lormeau JC, Choay J, Sié P, Boneu B.
    Thromb Res; 1988 Oct 15; 52(2):153-64. PubMed ID: 3194890
    [Abstract] [Full Text] [Related]

  • 19. Potentiation of the antithrombotic action of dermatan sulphate by small amounts of heparin.
    Thomas DP, Gray E, Merton RE.
    Thromb Haemost; 1990 Oct 22; 64(2):290-3. PubMed ID: 2270536
    [Abstract] [Full Text] [Related]

  • 20. The additive effect of low molecular weight heparins on thrombin inhibition by dermatan sulfate.
    Cosmi B, Agnelli G, Young E, Hirsh J, Weitz J.
    Thromb Haemost; 1993 Sep 01; 70(3):443-7. PubMed ID: 8259546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.